Workflow
C*Core Technology(688262)
icon
Search documents
晚间公告丨7月1日这些公告有看头
第一财经· 2025-07-01 13:14
Major Events - Newland has established a subsidiary in the US and obtained an MSB license to enhance its global payment business and facilitate cross-border payment operations [3] - Zhejiang Liming's actual controllers have committed not to reduce their shareholdings within one year [4] - Tengya Precision has announced a three-month commitment from its major shareholders not to reduce their holdings [6] - *ST Yuancheng is under investigation by the CSRC for suspected false financial disclosures [7] - Anglikang has only one innovative drug project currently under development, which is in the I phase of clinical trials [8] - Yongmaotai plans to invest approximately 450 million yuan to build an intelligent manufacturing base for auto parts in Mexico [9] - Fengfan Co. intends to acquire 100% equity of eight photovoltaic power station project companies for 48 million yuan [10] - Hangzhou High-tech is changing its controlling shareholder to Jirong Weiye and will resume trading on July 2 [11][12] - Zhongke Environmental Protection is acquiring 100% equity of two environmental companies for a total of 354 million yuan [13] - Yian Technology plans to increase its investment in its subsidiary Yihang Metal by 120 million yuan [14] - *ST Aowei has reported asset losses due to mismanagement by a processing partner [15] - XWANDA intends to issue H-shares and list on the Hong Kong Stock Exchange [16] - Baichuan Co.'s actual controller and chairman is under investigation [17] - Suzhou Planning is planning to acquire control of Dongjin Aviation Technology and will suspend trading [19] - Aerospace Changfeng plans to transfer 55.45% equity of a subsidiary through public listing [20] Performance Overview - Xinhecheng expects a net profit increase of 50%-70% for the first half of 2025, estimating between 3.3 billion to 3.75 billion yuan [21] - Shida Shenghua anticipates a net loss of 52 million to 60 million yuan for the first half of 2025 [22] - Kids' King expects a net profit increase of 50%-100% for the first half of 2025, estimating between 120 million to 160 million yuan [23] - SAIC Group reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [24] - BAIC Blue Valley's subsidiary reported a 139.73% increase in sales for the first half of 2025 [25] - Seris reported a 4.44% year-on-year increase in electric vehicle sales for June [26] - Great Wall Motors reported a 1.81% increase in total vehicle sales for the first half of 2025 [27] Major Contracts - Guoxin Technology has won a 46 million yuan project for automotive electronic chips [28] - Ankao Zhidian has signed two contracts for wind power transmission projects totaling 79.69 million yuan [29] Shareholding Changes - Wuxi Zhenhua's shareholder plans to reduce its stake by up to 1% [30] - Longxun Co. shareholders plan to reduce their holdings by up to 2% [31] - FJ Environmental's major shareholder plans to reduce its stake by up to 3% [32] - Yuexiu Capital's subsidiary plans to increase its stake in Yuexiu Real Estate [33] Financing Activities - Haoyuan Pharmaceutical plans to increase its subsidiary's capital by 400 million yuan through debt-to-equity conversion [34] - Hainan Huatie plans to issue bonds not exceeding 2 billion yuan to optimize its financing structure [35]
晚间公告丨7月1日这些公告有看头
Di Yi Cai Jing· 2025-07-01 10:54
Group 1: Company Announcements - Newland has established a foreign subsidiary, NovaPay US Inc., and obtained a US MSB license to enhance its global payment business and facilitate cross-border payment operations [3] - Zhejiang Liming's actual controllers have committed not to reduce their shareholdings in the company for one year starting from July 2, 2025 [4] - Tengya Precision has announced that its controlling shareholder and actual controller will not reduce their shareholdings for three months from July 1, 2025, to September 30, 2025 [5] - *ST Yuancheng is under investigation by the China Securities Regulatory Commission for suspected false financial disclosures, which may lead to significant legal consequences [6] - Anglikon has only one innovative drug project currently under research, which is in the I phase of clinical trials [7] - Yongmaotai plans to invest approximately 450 million yuan to build an intelligent manufacturing base for automotive parts in Mexico [8] - Fengfan Co. intends to acquire 100% equity of eight photovoltaic power station project companies for 48 million yuan to streamline its business structure [9] Group 2: Performance Forecasts - Xinhengcheng expects a net profit of 3.3 billion to 3.75 billion yuan for the first half of 2025, representing a year-on-year increase of 50% to 70% [11][12] - SAIC Motor reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [13] - BAIC Blue Valley's subsidiary saw a 139.73% year-on-year increase in sales for the first half of 2025 [14] - Kids King anticipates a net profit of 120 million to 160 million yuan for the first half of 2025, reflecting a year-on-year growth of 50% to 100% [15] Group 3: Major Contracts - Guoxin Technology has won a bid for an automotive electronic chip project worth 46 million yuan [17] - Ankao Smart Electric has signed two contracts for wind power transmission projects, totaling approximately 79.69 million yuan, which accounts for 7.34% of the company's projected revenue for 2024 [18] Group 4: Shareholding Changes - Wuxi Zhenhua's shareholder, Wuxi Kangsheng, plans to reduce its stake by up to 1%, equivalent to no more than 2.5 million shares [20]
电子身份证概念下跌2.52%,主力资金净流出33股
Group 1 - The electronic ID concept sector experienced a decline of 2.52%, ranking among the top losers in the concept sector, with Jida Zhengyuan hitting the limit down [1][2] - Among the stocks in the electronic ID sector, notable declines were seen in Xinguodu (-7.29%), Hengbao Shares (-3.97%), and Xiongdi Technology (-8.73%) [2][3] - Conversely, stocks that saw gains included Chutianlong (up 4.08%), ST Renzihang (up 2.43%), and Guoxin Technology (up 1.39%) [1][3] Group 2 - The electronic ID sector faced a net outflow of 1.997 billion yuan, with 33 stocks experiencing net outflows, and 7 stocks seeing outflows exceeding 100 million yuan [2] - The stock with the highest net outflow was Xinguodu, with a net outflow of 400 million yuan, followed by Hengbao Shares (270 million yuan) and Xiongdi Technology (215 million yuan) [2][3] - Stocks with the highest net inflow included Chutianlong (160 million yuan), Guoxin Technology (38.5 million yuan), and ST Renzihang (14.1 million yuan) [2][3]
7月1日晚间重要公告一览
Xi Niu Cai Jing· 2025-07-01 10:29
Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]
国芯科技(688262) - 关于收到汽车电子芯片项目中标通知书的自愿性披露公告
2025-07-01 09:00
证券代码:688262 证券简称:国芯科技 公告编号:2025-055 苏州国芯科技股份有限公司 关于收到汽车电子芯片项目中标通知书的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 ●苏州国芯科技股份有限公司(以下简称"公司")收到一家汽车整机厂商 关于供应汽车安全气囊点火驱动芯片项目的《中标通知书》,中标产品总价为 4,600万元人民币(未税)。 ●公司收到的中标通知书不构成实质性的供货合同,截至本公告披露日, 公司与客户尚未签订正式合同及交付产品,相关产品仍在进一步可靠性测试过程 中,产品的实际供货时间、供货价格、供货数量以公司与客户后续签订的正式供 货合同或销售订单及结算情况为准。公司将根据合同执行情况和收入确认政策对 项目收入进行确认。 公司于近日收到一家汽车整机厂商(限于保密要求,无法披露其名称,以下 简称"客户")的《中标通知书》,公司的汽车安全气囊点火驱动芯片中标该客户 的安全气囊项目。现将相关事项内容公告如下: 一、中标通知书概况 公司于近日收到客户的项目中标通知书,中标产品为公司的汽车安全 ...
国芯科技:公司中标汽车安全气囊点火驱动芯片项目,总价4600万元
news flash· 2025-07-01 08:30
Core Viewpoint - The company has received a bid notification for the supply of automotive airbag ignition driver chips, with a total project value of 46 million RMB (before tax), indicating strong recognition of its R&D capabilities, product quality, and supply chain capabilities [1] Group 1 - The total project value for the automotive airbag ignition driver chips is 46 million RMB (before tax) [1] - The bid reflects the client's full recognition of the company's R&D capabilities and product quality [1] - This win is expected to enhance the company's competitiveness and brand image in the automotive electronic chip market [1]
国芯科技(688262) - 关于自愿披露公司面向下一代48V电子电气架构研发的汽车电子安全气囊点火芯片新产品内部测试成功的公告
2025-06-30 08:00
苏州国芯科技股份有限公司 证券代码:688262 证券简称:国芯科技 公告编号:2025-054 关于自愿披露公司面向下一代 48V 电子电气架构研发的汽 车电子安全气囊点火芯片新产品内部测试成功的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 苏州国芯科技股份有限公司(以下简称"公司")研发的面向下一代48V电 子电气架构的汽车电子安全气囊点火芯片新产品"CCL1800B"于近日在公司内部 测试中获得成功。现将相关事项内容公告如下: 一、新产品的基本情况 公司本次新产品CCL1800B是业界首次公开发布成功研发的面向汽车电子48V 电子电气架构的安全气囊点火芯片。该芯片新产品在开发过程中与头部主机厂客 户进行了充分的需求征询和方案论证,截至目前为止尚未见业界其他同类相关产 品报道。 新能源汽车智能化正驱动汽车电气化的加速发展,智能化和电气化成为驱动 汽车产业升级的核心引擎,以智能化为核心的功能创新导致低压电源系统已从单 纯的能量分配网络,演进为支撑整车智能化的中枢系统;域控架构的快速迭代、 线控底盘以及日新月异的智 ...
苏州国芯科技申请一种PCIE密码卡及其通信方法、装置、介质专利,抵抗量子攻击
Jin Rong Jie· 2025-06-28 01:47
Group 1 - The core viewpoint of the news is that Suzhou Guoxin Technology Co., Ltd. has applied for a patent related to a PCIe cryptographic card and its communication methods, which aims to enhance security against quantum attacks [1] - The patent application was filed on April 2025, and the public announcement number is CN120223309A [1] - The technology involves a main PCIe chip device that includes a first PCIe endpoint port, a security algorithm engine, and a PCIe root complex port, designed to improve the reliability and security of cryptographic operations [1] Group 2 - Suzhou Guoxin Technology Co., Ltd. was established in 2001 and is primarily engaged in software and information technology services [2] - The company has a registered capital of approximately 335.99 million RMB [2] - The company has invested in 21 enterprises and participated in 53 bidding projects, holding 256 patents and 2 trademark registrations [2]
国芯科技: 首次公开发行部分限售股上市流通公告
Zheng Quan Zhi Xing· 2025-06-26 16:21
证券代码:688262 证券简称:国芯科技 公告编号:2025-053 苏州国芯科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ? 本次股票上市类型为首发限售股份;股票认购方式为网下,上市股数为 本次股票上市流通总数为71,649,273股。 ? 本次股票上市流通日期为2025 年 7 月 7 日。(因 2025 年 7 月 6 日为非交 易日,故顺延至下一交易日) 一、本次上市流通的限售股类型 经中国证券监督管理委员会于 2021 年 12 月 7 日出具的《关于同意苏州国芯 科技股份有限公司首次公开发行股票注册的批复》 (证监许可20213860 号)核准, 苏州国芯科技股份有限公司(以下简称"公司"、 "国芯科技"或"发行人")首次 向社会公众公开发行人民币普通股(A 股)股票 60,000,000 股,并于 2022 年 1 月 其中有限售条件流通股合计 186,743,902 股,无限售条件流通股合计 53,256,098 股。 本次上市流通的限售股为公司首次公开发行的部分限售股 ...
国芯科技(688262) - 首次公开发行部分限售股上市流通公告
2025-06-26 09:47
首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 证券代码:688262 证券简称:国芯科技 公告编号:2025-053 苏州国芯科技股份有限公司 本次股票上市类型为首发限售股份;股票认购方式为网下,上市股数为 71,649,273股。 本次股票上市流通总数为71,649,273股。 本次股票上市流通日期为2025 年 7 月 7 日。(因 2025 年 7 月 6 日为非交 易日,故顺延至下一交易日) 一、本次上市流通的限售股类型 经中国证券监督管理委员会于 2021 年 12 月 7 日出具的《关于同意苏州国芯 科技股份有限公司首次公开发行股票注册的批复》(证监许可[2021]3860 号)核准, 苏州国芯科技股份有限公司(以下简称"公司"、"国芯科技"或"发行人")首次 向社会公众公开发行人民币普通股(A 股)股票 60,000,000 股,并于 2022 年 1 月 6 日在上海证券交易所挂牌上市。公司首次公开发行后总股本为 240,000,000 股, 其中有限售 ...